Palatin Technologies, Inc. (PTN)
5.52
-0.47
(-7.85%)
USD |
NASDAQ |
Oct 20, 16:00
5.60
+0.08
(+1.45%)
After-Hours: 20:00
Palatin Technologies EPS Diluted (Quarterly) : -1.112 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.112 |
| March 31, 2026 | -0.3663 |
| December 31, 2025 | -2.860 |
| September 30, 2025 | 4.258 |
| June 30, 2025 | -2.398 |
| March 31, 2025 | -0.1826 |
| December 31, 2024 | -5.918 |
| September 30, 2024 | -0.3942 |
| June 30, 2024 | -0.4901 |
| March 31, 2024 | -0.5342 |
| December 31, 2023 | -0.5564 |
| September 30, 2023 | -21.39 |
| June 30, 2023 | -43.38 |
| March 31, 2023 | -37.92 |
| December 31, 2022 | 12.53 |
| September 30, 2022 | -0.8568 |
| June 30, 2022 | -1.338 |
| March 31, 2022 | -0.799 |
| December 31, 2021 | -0.9115 |
| September 30, 2021 | -0.7465 |
| June 30, 2021 | -1.514 |
| March 31, 2021 | -0.6048 |
| December 31, 2020 | -1.057 |
| September 30, 2020 | -0.4168 |
| June 30, 2020 | -0.7752 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.5718 |
| December 31, 2019 | -0.558 |
| September 30, 2019 | -0.4828 |
| June 30, 2019 | 5.713 |
| March 31, 2019 | -0.6918 |
| December 31, 2018 | -0.6105 |
| September 30, 2018 | -0.693 |
| June 30, 2018 | 1.50 |
| March 31, 2018 | -0.0935 |
| December 31, 2017 | 0.25 |
| September 30, 2017 | 1.25 |
| June 30, 2017 | 1.75 |
| March 31, 2017 | -0.50 |
| December 31, 2016 | -1.50 |
| September 30, 2016 | -2.00 |
| June 30, 2016 | -112.50 |
| March 31, 2016 | -2.00 |
| December 31, 2015 | -2.00 |
| September 30, 2015 | -2.00 |
| June 30, 2015 | -2.25 |
| March 31, 2015 | -1.75 |
| December 31, 2014 | 0.75 |
| September 30, 2014 | 0.25 |
| June 30, 2014 | -1.00 |
| March 31, 2014 | -0.25 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.359M |
| Revenue (Quarterly) | 0.3008M |
| Total Expenses (Quarterly) | 4.659M |
| Enterprise Value | 2.554M |
| Gross Profit Margin (Quarterly) | 94.35% |
| Profit Margin (Quarterly) | -1.45K% |
| Earnings Yield | -1.45% |
| Normalized Earnings Yield | -1.448 |